The Correlation of Lewis Antigens With VTE

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-78
SponsorLarissa University Hospital

About this trial

The goal of this observational study is to learn if certain factors in a person's blood are linked to a history of venous thromboembolic disease (VTED), which includes conditions like deep vein thrombosis.

Lewis system antigens are natural markers found on red blood cells. Past research suggests that people without these specific markers might have a higher chance of developing heart disease, but the link to blood clots in veins is not well understood.

This study aims to answer:

* Are certain Lewis antigen types more common in people with a history of VTE? * Do the Lewis antigen results relate to other known blood clot risk factors? Researchers will identify Lewis a and b antigens in 100 participants who attend the Haemostasis Disorders Clinic at the University Hospital of Larissa. All participants are people with a personal history of deep vein thrombosis, with or without an inherited or acquired tendency for blood clots.

Researchers will also record other known risk factors for VTED for each participant. This study is self-funded.

Eligibility criteria

Qualifiers

Adult patients aged 18-78 years with a personal history of deep venous thrombosis and/or Pulmonary Embolism.

Disqualifiers

Current pregnancy or postpartum period 2. Hepatic insufficiency 3. Alcoholic cirrhosis

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

200 Participants
are grouped into 2 trial groups

Locations

This trial has no locations

Sponsors and collaborators